Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Recurrent Ovarian Cancer: PARP Inhibitor Maintenance Therapy

April 29th 2019

Advanced OC: Clinical Data Behind PARP Inhibition

April 29th 2019

Evolution of PARP Inhibitors in Advanced Ovarian Cancer

April 29th 2019

Comprehensive Review of Maintenance Therapy in Advanced OC

April 29th 2019

Frontline Therapy and Recurrence in Advanced Ovarian Cancer

April 29th 2019

Recommended Approaches to Treating Advanced Ovarian Cancer

April 29th 2019

Advanced Ovarian Cancer: Role of Non-BRCA Mutations

April 29th 2019

Optimizing BRCA Testing in Advanced Ovarian Cancer

April 29th 2019

Role of BRCA Mutations in Advanced Ovarian Cancer

April 29th 2019

Advanced Ovarian Cancer: Evaluating Prognoses

April 29th 2019

Oncology Surgeons Need Better Training in Palliative Care

April 24th 2019

It is important for oncology surgeon trainees to learn to recognize when a palliative surgical procedure for an advanced malignancy might be appropriate, be familiar with the conduct of these operations, and understand the nuances of postoperative care and management of complications in this unique patient population.

Emerging Approaches for BRAF-Mutant Metastatic Melanoma

March 28th 2019

Treatment Sequencing in BRAF+ Metastatic Melanoma

March 28th 2019

Treatment Adherence and Response With BRAF-Targeted Therapy

March 28th 2019

BRAF/MEK Frontline Therapy in Metastatic Melanoma

March 28th 2019

Maximizing BRAF/MEK Inhibition in Melanoma

March 28th 2019

Recommendations for Managing BRAF+ Metastatic Melanoma

March 28th 2019

BRAF-Targeted Therapy in Melanoma: Toxicity Management

March 28th 2019

Treating Melanoma Patients With BRAF/MEK Dual-Targeted Therapy

March 28th 2019

The COLUMBUS Trial in BRAF-Mutant Melanoma

March 28th 2019